Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
HEALTHCARE
(NY:
XLV
)
157.20
+1.08 (+0.69%)
Official Closing Price
Updated: 6:30 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HEALTHCARE
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
21
22
Next >
Tuesday Talk: My Sweet CPI
February 14, 2023
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday.
Via
Talk Markets
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
February 13, 2023
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends.
Via
Talk Markets
A Bull Market Is Coming. Should You Return to Growth Stocks?
February 11, 2023
Growth stocks could be among the first to rally in a bull market.
Via
The Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
February 02, 2023
Funneling money into this fund can drastically simplify your investing strategy.
Via
The Motley Fool
10 Names For Half The Move
February 01, 2023
In January, sectors like Tech, Communication Services, and Consumer Discretionary saw massive outperformance following the opposite playing out throughout 2022.
Via
Talk Markets
Budding Sign Not To Miss
January 03, 2023
Encouraging signs from corporate junk bonds, stocks are likely to get a tailwind to open 2023.
Via
Talk Markets
Small-Caps Set To Sizzle
October 31, 2022
Via
Talk Markets
Sector Divergence, Earnings Stats
January 31, 2023
Over these last few weeks, as the broad market has rallied, we've definitely seen some sector divergence.
Via
Talk Markets
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
January 30, 2023
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.
Via
Talk Markets
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
January 23, 2023
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.
Via
Talk Markets
Rotating Regimes – What To Plan For In 2023
January 21, 2023
Throughout the second half of 2022, active managers turned to sector rotation to help mitigate and recover from substantial losses incurred already. Rotation into and out of low and high volatility...
Via
Talk Markets
Markets At Key Turning Point With Major Earnings Ahead
January 17, 2023
We saw initial selling in the market today and will be watching this particular key price level very closely this week and beyond.
Via
Talk Markets
Top Sector For 2023
January 17, 2023
Technical analysis and opinion on each sector in the stock market and which ones are likely to do the best, and which ones are most likely to lag the overall market.
Via
Talk Markets
Best ETFs, Funds, and Stocks of 2022. A Preview to 2023.
January 14, 2023
In 2022, high inflation and rising bond yields emerged as headwinds for stocks. The S&P 500 declined by over 18%, marking its worst yearly showing since 2008.
Via
Talk Markets
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
January 12, 2023
Small-cap speculative biotech stocks regain interest with volatility.
Via
Talk Markets
Market Awaits The CPI And Financial Earnings - Be Ready!
January 10, 2023
A look at the upcoming big events this week, which stocks are leading the rally with double-digit gains so far in 2023 and which smaller number of stocks started the year weak.
Via
Talk Markets
Biden, Trump, DeSantis: Cramer Says Concerns Over Next President Mean We May Be In For 'Second Leg' Of 'Vicious Rotation' Out Of Healthcare
January 10, 2023
The Health Care Select Sector SPDR Fund (NYSE: XLV) ended 2022 with a modest loss of 2.08%, a relative outperformance vis-a-vis the broader S&P 500 Index,
Via
Benzinga
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
January 04, 2023
By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk.
Via
The Motley Fool
Leading And Lagging Sectors For January 3, 2023
January 03, 2023
Gainers Symbol Name Price Change ($) Change (%) Volume
Via
Benzinga
Investing In 2023 - The Crucial Events Driving The Markets
January 03, 2023
Business decisions drive the business cycle. These decisions will impact the markets in 2023 and beyond.
Via
Talk Markets
The Year In Review And Ahead
December 29, 2022
We‘ll continue witnessing cost-push inflation combined with tight labor market – and it would be crude oil‘s time again to gain in value from current levels.
Via
Talk Markets
2022 Review: US Equity Sectors
December 29, 2022
Annual returns for equity sectors are always a study in contrasts, but the blowout performance of energy stocks in 2022 is unusually divergent vs. the rest of the field.
Via
Talk Markets
AI Stock Forecast: Fighting The Irrational Crowd By Investing Through AI
December 18, 2022
Deviation from rational thinking creates direct losses or opportunity costs in investing activity. AI can capture our biases and feelings, and uncover the knowledge that is covered for a general...
Via
Talk Markets
Has The Final Leg Of The Bear Market Begun?
December 10, 2022
The S&P 500 experienced a momentum reversal this week. What can we learn from history and a wide variety of charts and data sets?
Via
Talk Markets
Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead
November 28, 2022
Healthcare stocks are now favored by many strategists because of their defensive nature and focus on US markets.
Via
Talk Markets
A Stalwart Delivers
November 22, 2022
Since August, volatility has risen for all S&P 500 sectors, with Consumer Discretionary and Energy maintaining their status as the most volatile sectors.
Via
Talk Markets
Leading And Lagging Sectors For November 18, 2022
November 18, 2022
Gainers Symbol Name Price Change ($) Change (%) Volume
Via
Benzinga
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
The (Alarm) Bells Are Ringing For Me And My Gal
November 15, 2022
It is entirely reasonable with persistent inflation at current levels for S&P 500 earnings to come down to levels far lower than currently projected.
Via
Talk Markets
Visualizing S&P 500 Performance In 2022, By Sector
November 01, 2022
Tracking indexes over the course of a year reveals a lot about market trends and sentiment. The S&P 500’s performance over the course of 2022 is a great example.
Via
Talk Markets
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.